Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cosmetic outcome in patients with early stage breast cancer after accelerated partial breast irradiation using intraoperative or external beam radiotherapy.
Gunster JLB, Jacobs DHM, Mast ME, Verbeek-de Kanter A, Fisscher UJ, Petoukhova AL, Speijer G, Straver M, Merkus J, Marijnen CAM, Scholten AN. Gunster JLB, et al. Among authors: jacobs dhm. Clin Transl Radiat Oncol. 2024 Aug 18;49:100844. doi: 10.1016/j.ctro.2024.100844. eCollection 2024 Nov. Clin Transl Radiat Oncol. 2024. PMID: 39308632 Free PMC article.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension.
Nowak RJ, Breiner A, Bril V, Allen JA, Khan S, Levine T, Jacobs DH, Sahagian G, Siddiqi ZA, Xu J, Macias WL, Benatar M; ASCEND MG Study Group. Nowak RJ, et al. Among authors: jacobs dh. Ann Clin Transl Neurol. 2024 Jan;11(1):194-206. doi: 10.1002/acn3.51946. Epub 2023 Dec 7. Ann Clin Transl Neurol. 2024. PMID: 38062618 Free PMC article. Clinical Trial.
A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment.
Monane M, Johnson KG, Snider BJ, Turner RS, Drake JD, Maraganore DM, Bicksel JL, Jacobs DH, Ortega JL, Henderson J, Jiang Y, Huang S, Coppinger J, Fogelman I, West T, Braunstein JB. Monane M, et al. Among authors: jacobs dh. Ann Clin Transl Neurol. 2023 Oct;10(10):1738-1748. doi: 10.1002/acn3.51863. Epub 2023 Aug 7. Ann Clin Transl Neurol. 2023. PMID: 37550958 Free PMC article.
Accelerated Partial Breast Irradiation Using External Beam or Intraoperative Electron Radiation Therapy: 5-Year Oncological Outcomes of a Prospective Cohort Study.
Jacobs DHM, Mast ME, Horeweg N, Speijer G, Petoukhova AL, Straver M, Coerkamp EG, Hazelbag HM, Merkus J, Roeloffzen EMA, Zwanenburg LG, van der Sijp J, Fiocco M, Marijnen CAM, Koper PCM. Jacobs DHM, et al. Int J Radiat Oncol Biol Phys. 2022 Jul 1;113(3):570-581. doi: 10.1016/j.ijrobp.2022.03.010. Epub 2022 Mar 15. Int J Radiat Oncol Biol Phys. 2022. PMID: 35301990
Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens.
Jacobs DHM, Charaghvandi RK, Horeweg N, Maduro JH, Speijer G, Roeloffzen EMA, Mast M, Bantema-Joppe E, Petoukhova AL, van den Bongard DHJG, Koper P, Crijns APG, Marijnen CAM, Verkooijen HM. Jacobs DHM, et al. Breast Cancer Res Treat. 2021 Sep;189(2):387-398. doi: 10.1007/s10549-021-06314-4. Epub 2021 Jul 3. Breast Cancer Res Treat. 2021. PMID: 34216316 Free PMC article.
51 results